Literature DB >> 14977769

Small margin excision of periocular basal cell carcinoma: 5 year results.

J D Hsuan1, R A Harrad, M J Potts, C Collins.   

Abstract

BACKGROUND: The traditional surgical management of nodular adnexal basal cell carcinomas (BCC) involves excision with 3-4 mm margins and primary repair. This may remove a significant area of healthy tissue, often necessitating a complicated reconstruction, without the confirmation that tumour excision is complete.
METHODS: Nodular adnexal BCCs were excised with 2 mm margins, and the repair delayed for 2 days, providing time for histological confirmation of complete excision with formal paraffin sections. Any incompletely excised tumours underwent further resection, which was facilitated by the undisturbed wound edges. Repair was again delayed until further histological examination had confirmed complete excision.
RESULTS: 5 year follow up data were available for 55 patients who had undergone small margin BCC excision with delayed repair. 10 patients required more than one excision to achieve clear margins. There were no recurrences.
CONCLUSION: Small margin excision of nodular adnexal BCCs with delayed repair is a safe and efficient method. Delayed repair allows histological confirmation of complete excision and assists further resection if required. Preservation of healthy tissue is maximised allowing less radical reconstructive surgery without resorting to Mohs' labour intensive technique.

Entities:  

Mesh:

Year:  2004        PMID: 14977769      PMCID: PMC1772028          DOI: 10.1136/bjo.2003.018531

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  16 in total

Review 1.  Comparison of methods for checking surgical margins.

Authors:  R P Rapini
Journal:  J Am Acad Dermatol       Date:  1990-08       Impact factor: 11.527

2.  Conventional frozen sections in periocular basal-cell carcinoma: a review of 236 cases.

Authors:  H J Glatt; J J Olson; A M Putterman
Journal:  Ophthalmic Surg       Date:  1992-01

3.  Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream.

Authors:  K R Beutner; J K Geisse; D Helman; T L Fox; A Ginkel; M L Owens
Journal:  J Am Acad Dermatol       Date:  1999-12       Impact factor: 11.527

Review 4.  Incidence of nonmelanoma skin cancer.

Authors:  F Urbach
Journal:  Dermatol Clin       Date:  1991-10       Impact factor: 3.478

Review 5.  Basal cell carcinoma of the eyelid and periocular skin.

Authors:  C E Margo; K Waltz
Journal:  Surv Ophthalmol       Date:  1993 Sep-Oct       Impact factor: 6.048

6.  Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota.

Authors:  B E Cook; G B Bartley
Journal:  Ophthalmology       Date:  1999-04       Impact factor: 12.079

7.  Surgical margins for basal cell carcinoma.

Authors:  D J Wolf; J A Zitelli
Journal:  Arch Dermatol       Date:  1987-03

8.  Photodynamic therapy for the treatment of basal cell carcinoma.

Authors:  B D Wilson; T S Mang; H Stoll; C Jones; M Cooper; T J Dougherty
Journal:  Arch Dermatol       Date:  1992-12

9.  Micrographic (MOHS') surgery in the management of periocular basal cell epitheliomas.

Authors:  R N Downes; N P Walker; J R Collin
Journal:  Eye (Lond)       Date:  1990       Impact factor: 3.775

10.  Micrographic surgery for the microscopically controlled excision of eyelid cancers.

Authors:  F E Mohs
Journal:  Arch Ophthalmol       Date:  1986-06
View more
  11 in total

1.  Mohs surgery: efficient and effective.

Authors:  C C Otley; S J Salasche
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

2.  Confident complete excision of lid-margin BCCs using a marginal strip: an alternative to Mohs' surgery.

Authors:  Narendra Dhingra; Adam Gajdasty; Jim W Neal; Achyut N Mukherjee; Carol M Lane
Journal:  Br J Ophthalmol       Date:  2007-01-17       Impact factor: 4.638

3.  5 years review of periocular basal cell carcinoma and proposed follow-up protocol.

Authors:  S F Ho; L Brown; M Bamford; R Sampath; J Burns
Journal:  Eye (Lond)       Date:  2012-11-16       Impact factor: 3.775

4.  Eyelid basal cell carcinoma: non-Mohs excision, repair, and outcome.

Authors:  S Hamada; T Kersey; V T Thaller
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

5.  Periocular basal cell carcinoma results and surgical outcome during a 5-year period in a larger Danish population.

Authors:  Sveina Björk Karlsdóttir; Simon Johannessen; Nikolaj Carsting Bjerrum; Ulrik Frydkjær-Olsen; Søren Leer Blindbæk; Flemming Møller; Camilla Wellejus
Journal:  BMC Ophthalmol       Date:  2022-06-28       Impact factor: 2.086

6.  A technique for the reconstruction of lower eyelid marginal defects.

Authors:  Ingemarie Moesen; Dion Paridaens
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

7.  Sequential occurrence of basal cell carcinoma in symmetrically identical positions of both lower eyelids: A rare finding of a common skin cancer.

Authors:  Shanti Pandey; Vimlesh Sharma; G S Titiyal; Vivekanand Satyawali
Journal:  Oman J Ophthalmol       Date:  2010-09

8.  Subclinical infiltration of Basal cell carcinoma in asian patients: assessment after mohs micrographic surgery.

Authors:  Ki Woong Ro; Soo Hong Seo; Sang Wook Son; Il-Hwan Kim
Journal:  Ann Dermatol       Date:  2011-08-06       Impact factor: 1.444

9.  Superpulsed CO 2 Laser with Intraoperative Pathologic Assessment for Treatment of Periorbital Basal Cell Carcinoma Involving Eyelash Line.

Authors:  Ali Ebrahimi; Mansour Rezaei; Reza Kavoussi; Mojtaba Eidizadeh; Seyed Hamid Madani; Hossein Kavoussi
Journal:  Dermatol Res Pract       Date:  2014-10-13

Review 10.  Metatypical basal cell carcinoma: a clinical review.

Authors:  Mauro Tarallo; Emanuele Cigna; Riccardo Frati; Sergio Delfino; Daniele Innocenzi; Umberto Fama; Annamaria Corbianco; Nicolò Scuderi
Journal:  J Exp Clin Cancer Res       Date:  2008-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.